IRLAB Therapeutics AB engages in the provision of novel treatments for disorders of the brain that focuses on illness in the central nervous system. The fim develops drugs for Parkinson's disease. It also offers IRL752 that targets dementia in Parkinson's disease. The company was founded in 2013 and is headquartered in Gothenburg, Sweden.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is the 52-week high for IRLAB Therapeutics AB - Ordinary Shares - Class A?
52 week high is the highest price of a stock in the past 52 weeks, or one year. IRLAB Therapeutics AB - Ordinary Shares - Class A 52 week high is $0.10 as of October 10, 2026.
What is the 52-week low for IRLAB Therapeutics AB - Ordinary Shares - Class A?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. IRLAB Therapeutics AB - Ordinary Shares - Class A 52 week low is $0.10 as of October 10, 2026.
What is IRLAB Therapeutics AB - Ordinary Shares - Class A stock price today?
IRLAB Therapeutics AB - Ordinary Shares - Class A stock price today is $0.10.
What is the 50-day moving average of IRLAB Therapeutics AB - Ordinary Shares - Class A?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. IRLAB Therapeutics AB - Ordinary Shares - Class A 50-day moving average is $0.01.